All posts by: Tasly

About Tasly
March 7, 2023

Tasly Pharmaceuticals to Participate in Trade Winds ASEAN Mission and Business Forum

Bio-pharmaceutical company to explore collaboration opportunities during largest U.S. government-led trade and business development event Rockville, MD – March 7, 2023 – Tasly Pharmaceuticals, Inc. (Tasly U.S.), “dedicated to a healthier world,” will participate in the Trade Winds ASEAN Mission and Business Forum March 13-15 in Bangkok, Thailand.  The Trade Winds event, organized by the […]

July 15, 2022

What makes Tasly a great company to invest in?

If you are interested in influencing the future of medicine by improving the quality of life for individuals in the United States and around the world, you should consider investing in Tasly U.S.  Traditional Chinese Medicine (TCM) is the focus of our research and development, and we would like to incorporate the practices that have […]

June 10, 2022

Cardiovascular (T89) Drug Updates

Tests show it can reduce chronic stable angina. Tasly Pharmaceuticals Inc(Tasly US), is nearing the end of what has been a long road of testing to get approval from the US Food and Drug Administration (FDA) for its T89 drug (Dantonic), multiple components innovative Chinese Medicine (ICM). Dantonic, the drug has been shown to have few […]

May 18, 2022

Tasly in Cooperation with Azurity on T89 R&D and Marketing

Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Azurity Pharmaceuticals, Inc. (referred to as “Azurity”) announced on Sep. 6 comprehensive cooperation in the R&D and marketing of T89 in the States. According to their agreement, Azurity will contribute an amount up to US$23 million for T89-related clinical research and […]

May 17, 2018

Tasly Presents Breakthrough Angina Herbal Compound to American College of Cardiologists

ROCKVILLE, MD – Tasly Pharmaceuticals Co. Ltd. of China and Tasly Pharmaceuticals, Inc. of USA, a global leader in pharmaceuticals, biologics and nutraceuticals, announced that its three-herb composition drug T89 (Dantonic), has been shown in a Phase 3 global clinical trial to improve Treadmill exercise duration (TED) and more effectively reduce the frequency of chronic […]

May 17, 2018

Dr. Henry Sun Gives Keynote at ACC18 on Herbal Therapy for Heart Disease

On March 12, 2018, Dr. Henry Sun, Ph.D., and CEO/President of Tasly Pharmaceuticals, Inc. took the stage at this year’s American College of Cardiology (ACC) conference as a keynote speaker to present on a new topic. He spoke about the future of herbal therapies to support heart disease treatments, citing a recent completion of a […]

February 3, 2015

An Important Announcement from Our CEO

To Our Valued Customers, Patients, Healthcare Providers, and Business Partners, On February 3, 2015, the New York State Attorney General’s Office accused four national retailers of selling dietary supplements that were fraudulent and in many cases contaminated with unlisted ingredients.  Although we cannot comment on this and will not make any assumptions of what is […]

August 27, 2014

Tasly Comes to America

Rockville, MD – PR Newswire – 27 August 2014 – On September 3, 2014, Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, hosted a ribbon-cutting event at its corporate headquarters in Rockville, Maryland. The ceremony included over 150 distinguished guests and dignitaries, including Tasly’s corporate leaders, Maryland state officials, high-level media representatives, […]